OpenProtein.AI provides a no-code platform and models for protein design, enabling biologists to use AI without deep ML expertise, with Boehringer Ingelheim expanding collaboration.
OpenProtein. AI offers a web-based platform and APIs for designing and predicting proteins using its PoET models. The platform aims to broaden access to AI-driven biology tools for academia and industry.
Boehringer Ingelheim extended its collaboration to embed OpenProtein’s tools into therapeutic protein engineering initiatives.
Lead coverage: MIT News AI — Bringing AI-driven protein-design tools to biologists everywhere ↗
OpenProtein. AI offers a web-based platform and APIs for designing and predicting proteins using its PoET models. The platform aims to broaden access to AI-driven biology tools for academia and industry.
Boehringer Ingelheim extended its collaboration to embed OpenProtein’s tools into therapeutic protein engineering initiatives.